Download full-text PDF

Source
http://dx.doi.org/10.1227/ons.0000000000000457DOI Listing

Publication Analysis

Top Keywords

commentary resection
4
resection giant
4
giant craniopharyngioma
4
craniopharyngioma contending
4
contending multiple
4
multiple compartments
4
compartments myriad
4
myriad perforating
4
perforating arteries
4
arteries 2-dimensional
4

Similar Publications

Neoadjuvant or perioperative immunotherapy for resectable melanoma: The need for biomarkers.

Eur J Cancer

January 2025

National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Electronic address:

Groundbreaking studies have reshaped the treatment landscape for patients with resectable stage ≥IIIB melanoma by demonstrating the benefits of neoadjuvant therapy. Data from the NADINA and SWOG S1801 trials reveal substantial improvements in event-free survival compared to adjuvant therapy alone. These studies employed distinct neoadjuvant immunotherapy approaches - ipilimumab plus nivolumab in NADINA and anti-PD-1 monotherapy in SWOG S1801 - highlighting potential differences in efficacy and toxicity.

View Article and Find Full Text PDF

Inflammatory bowel disease, particularly Crohn's disease (CD), has been linked to modifications in mesenteric adipose tissue (MAT) and the phenomenon known as "creeping fat" (CrF). The presence of CrF is believed to serve as a predictor for early clinical recurrence following surgical intervention in patients with CD. Notably, the incorporation of the mesentery during ileocolic resection for CD has been correlated with a decrease in surgical recurrence, indicating the significant role of MAT in the pathogenesis of CD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!